cilostazol has been researched along with tyrosine in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (25.00) | 18.2507 |
2000's | 3 (75.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adachi, T; Kimura, Y; Marukawa, K; Matsumoto, Y; Okumura, H; Tani, T | 1 |
Ito, H; Kimura, Y; Ozeki, Y; Sudo, T | 1 |
Ito, H; Miyakoda, G; Mori, T | 1 |
Hong, KW; Kim, CD; Lee, JH; Lee, WS; Park, SY; Rhim, BY | 1 |
4 other study(ies) available for cilostazol and tyrosine
Article | Year |
---|---|
Comparative study of antiplatelet drugs in vitro: distinct effects of cAMP-elevating drugs and GPIIb/IIIa antagonists on thrombin-induced platelet responses.
Topics: Abciximab; Alprostadil; Antibodies, Monoclonal; Blood Platelets; Cells, Cultured; Cilostazol; Cyclic AMP; Drug Evaluation, Preclinical; Hemostatics; Humans; Immunoglobulin Fab Fragments; Male; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Tetrazoles; Thrombin; Tirofiban; Tyrosine | 1999 |
Estimation of anti-platelet drugs on human platelet aggregation with a novel whole blood aggregometer by a screen filtration pressure method.
Topics: Adenosine Diphosphate; Amino Acid Chloromethyl Ketones; Aspirin; Blood Coagulation; Blood Platelets; Cilostazol; Collagen; Dipyridamole; Filtration; Heparin; Humans; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Count; Platelet Function Tests; Pressure; Tetrazoles; Time Factors; Tirofiban; Tyrosine | 2001 |
Cilostazol inhibits platelet-leukocyte interaction by suppression of platelet activation.
Topics: Antibodies, Monoclonal; Aspirin; Blood Platelets; Calcium; Cell Separation; Cilostazol; Collagen; Cyclic AMP; Humans; Leukocytes; Male; P-Selectin; Platelet Activation; Platelet Adhesiveness; Platelet Glycoprotein GPIIb-IIIa Complex; Tetrazoles; Thrombin; Tirofiban; Tyrosine | 2004 |
Beneficial synergistic effects of concurrent treatment with cilostazol and probucol against focal cerebral ischemic injury in rats.
Topics: Animals; Antioxidants; Apoptosis; Biomarkers; Brain Ischemia; Caspase 3; Cerebral Infarction; Chemotaxis, Leukocyte; Cilostazol; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Infarction, Middle Cerebral Artery; Male; Neuroprotective Agents; Peroxidase; Poly(ADP-ribose) Polymerases; Probucol; Rats; Rats, Sprague-Dawley; Superoxides; Telencephalon; Tetrazoles; Treatment Outcome; Tyrosine | 2007 |